메뉴 보기
link 세부 정보
정보 바로가기 : Curocell secures approval to begin phase 2 CAR-T therapy trial for adult ...
Curocell secures approval to begin phase 2 CAR-T therapy trial for adult ...[카테고리 설정이 아직되어 있지 않습니다.]
The primary endpoint is overall complete remission rate (OCR), with secondary measures including time to response (TTR), duration of response (DOR), and relapse-free survival (RFS). Adult ALL is...
